X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (385) 385
Paper (126) 126
Patent (120) 120
Publication (119) 119
Book / eBook (12) 12
Conference Proceeding (6) 6
Book Chapter (2) 2
Magazine Article (2) 2
Compact Disc (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
nuclear experiment (135) 135
experiment (131) 131
chemistry (120) 120
compositions based thereon (118) 118
metallurgy (118) 118
organic macromolecular compounds (118) 118
their preparation or chemical working-up (118) 118
physics (117) 117
nuclear physics (109) 109
macromolecular compounds obtained by reactions only involvingcarbon-to-carbon unsaturated bonds (97) 97
high energy physics - experiment (79) 79
index medicus (73) 73
humans (63) 63
general tagging of cross-sectional technologies spanning over several sections of the ipc (57) 57
general tagging of new technological developments (57) 57
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (57) 57
particle physics (56) 56
male (51) 51
[ phys.nexp ] physics [physics]/nuclear experiment [nucl-ex] (50) 50
climate change mitigation technologies in the production orprocessing of goods (49) 49
technologies or applications for mitigation or adaptation againstclimate change (49) 49
female (48) 48
high energy physics (47) 47
middle aged (37) 37
cern lhc coll (35) 35
compositions of macromolecular compounds (33) 33
[phys.nexp]physics [physics]/nuclear experiment [nucl-ex] (32) 32
alice (32) 32
nucl (32) 32
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (31) 31
experimental results (29) 29
hep (27) 27
lead (27) 27
aged (26) 26
rapidity (26) 26
transverse momentum (26) 26
animals (25) 25
cardiac & cardiovascular systems (24) 24
ex (23) 23
matematikk og naturvitenskap: 400::fysikk: 430::kjerne- og elementærpartikkelfysikk: 431 [vdp] (23) 23
mathematics and natural scienses: 400::physics: 430::nuclear and elementary particle physics: 431 [vdp] (23) 23
114 physical sciences (22) 22
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (22) 22
analysis (22) 22
nuclear and high energy physics (22) 22
mortality (21) 21
organic chemistry (21) 21
physics of elementary particles and fields (21) 21
technical subjects covered by former uspc (21) 21
technical subjects covered by former uspc cross-reference artcollections [xracs] and digests (21) 21
adult (20) 20
physics - nuclear experiment (20) 20
chemical or physical processes, e.g. catalysis or colloidchemistry (19) 19
monte carlo (19) 19
myocardial infarction (19) 19
performing operations (19) 19
physical or chemical processes or apparatus in general (19) 19
their relevant apparatus (19) 19
transporting (19) 19
heavy ion: scattering (18) 18
nuclear physics - experiment (18) 18
rats (18) 18
naturvetenskap (16) 16
fysik (15) 15
natural sciences (15) 15
percutaneous coronary intervention (15) 15
physical sciences (15) 15
risk factors (15) 15
rats, wistar (14) 14
subatomic physics (14) 14
subatomär fysik (14) 14
treatment outcome (14) 14
abridged index medicus (13) 13
cardiovascular (13) 13
heart attacks (13) 13
medicine, general & internal (13) 13
neurosciences (13) 13
p p: scattering (13) 13
physics, particles & fields (13) 13
time projection chamber (13) 13
acute coronary syndrome (12) 12
heavy ion experiments (12) 12
numerical calculations (12) 12
peripheral vascular disease (12) 12
risk (12) 12
thrombosis (12) 12
acyclic, carbocyclic or heterocyclic compounds containingelements other than carbon, hydrogen, halogen, oxygen, nitrogen,sulfur, selenium or tellurium (11) 11
correlation (11) 11
double-blind method (11) 11
engineering (11) 11
multidisciplinary sciences (11) 11
nuclear theory (11) 11
nucleus (11) 11
particle physics - experiment (11) 11
phenomenology (11) 11
physics and astronomy (11) 11
stroke (11) 11
ticlopidine - analogs & derivatives (11) 11
acute coronary syndromes (10) 10
acyclic or carbocyclic compounds (10) 10
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
UTL at Downsview - May be requested (6) 6
Robarts - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Music - Circulation Desk (1) 1
Music - Library use only (1) 1
Music - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Victoria University E.J. Pratt - Virginia Woolf (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (482) 482
French (51) 51
Hungarian (49) 49
German (36) 36
Chinese (20) 20
Spanish (5) 5
Czech (1) 1
Italian (1) 1
Latin (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Orvosi Hetilap, ISSN 0030-6002, 09/2016, Volume 157, Issue 38, pp. 1507 - 1510
Journal Article
Journal Article
Orvosi Hetilap, ISSN 0030-6002, 12/2012, Volume 153, Issue 51, pp. 2016 - 2020
Journal Article
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10081, pp. 1799 - 1808
Summary Background Dual antiplatelet therapy (DAPT), aspirin plus a P2Y12 inhibitor, is the standard antithrombotic treatment following acute coronary... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | PRACTICE GUIDELINES | MYOCARDIAL-INFARCTION | STENT THROMBOSIS | IN-VIVO | AMERICAN-COLLEGE | ASSOCIATION TASK-FORCE | PHASE-II | ST-SEGMENT ELEVATION | SECONDARY PREVENTION | ANTIPLATELET THERAPY | Purinergic P2Y Receptor Antagonists - administration & dosage | Ticlopidine - therapeutic use | Humans | Middle Aged | Male | Myocardial Infarction - diagnostic imaging | Rivaroxaban - administration & dosage | Aspirin - administration & dosage | Coronary Angiography - methods | Adenosine - therapeutic use | Thrombolytic Therapy - methods | Ticlopidine - administration & dosage | Female | Myocardial Infarction - physiopathology | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Ticagrelor | Electrocardiography - methods | Purinergic P2Y Receptor Antagonists - therapeutic use | Rivaroxaban - therapeutic use | Double-Blind Method | Treatment Outcome | Adenosine - administration & dosage | Ticlopidine - analogs & derivatives | Acute Coronary Syndrome - drug therapy | Drug Therapy, Combination - methods | Factor Xa Inhibitors - therapeutic use | Myocardial Infarction - drug therapy | Adenosine - analogs & derivatives | Clopidogrel | Aged | Hemorrhage - chemically induced | Medical research | Medical colleges | Aspirin | Mortality | Cardiac patients | Clinical trials | Medicine, Experimental | Dosage and administration | Research institutes | France | Coronary heart disease | Analysis | Myocardial infarction | Therapy | Angiography | Medical services | Disorders | Angina | Bleeding | Elevation | Randomization | Motivation | Atherosclerosis | Bioindicators | Safety | Drug therapy | Drug dosages | Heart diseases | Anticoagulants | Research & development--R&D | Strata | Coronary artery | Patients | Thrombosis | Thrombolysis | Inhibitors | Arteriosclerosis | Biomarkers | Infarction | Acute coronary syndromes | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
JAMA, ISSN 0098-7484, 09/2014, Volume 312, Issue 10, pp. 1006 - 1015
Journal Article